A Study of RAY1225 in Participants With Impaired Liver Function

Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic Function

NCT05126329 ·Status: TERMINATED ·Phase: PHASE1

KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment

NCT04166942 ·Status: COMPLETED ·Phase: PHASE1

Effect of Hepatic Impairment on LDE225..

NCT01764776 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State

NCT07297940 ·Status: COMPLETED ·Phase: PHASE1

An Investigational Study of SHR6390 in Participants With Mild to Moderate Liver Impairment and Healthy Participants

NCT04631575 ·Status: UNKNOWN ·Phase: PHASE1

A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function

NCT02005744 ·Status: COMPLETED ·Phase: PHASE1

An Investigational Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy Participants

NCT04631549 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics Properties of Single Oral Dosing of Lu AE58054 in Subjects With Hepatic Impairment (Mild and Moderate) and in Healthy Subjects

NCT02231450 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function

NCT04116476 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011

NCT02388620 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics of PCI-32765 in Participants With Varying Degrees of Hepatic Impairment

NCT01767948 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment

NCT03289234 ·Status: COMPLETED ·Phase: PHASE1

Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.

NCT00432627 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment

NCT07282093 ·Status: RECRUITING ·Phase: PHASE1

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers

NCT04019743 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Pharmacodynamics and Safety of SHR4640 in Patients With Hepatic Impairment

NCT04305392 ·Status: UNKNOWN ·Phase: PHASE1

STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT

NCT04604496 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment

NCT06352528 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

NCT05517525 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants

NCT04960124 ·Status: COMPLETED ·Phase: PHASE1

A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers

NCT01592890 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of RLX030 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy Subjects

NCT01433458 ·Status: COMPLETED ·Phase: PHASE1

PK Study of T-817 in Subjects With Hepatic Impairment

NCT02693197 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects

NCT04643795 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Safety and Tolerability of ITF2357 in Participants With Chronic Hepatic Impairment and With Normal Hepatic Function

NCT06736223 ·Status: COMPLETED ·Phase: PHASE1